[1] |
CAO Qinhan, ZHUO Xiao, XIA Yuhan, CHE Yangxi, CHEN Min.
Interpretation of Updated NCCN Clinical Guidelines for Rectal Cancer (2024.V1/V2)
[J]. Chinese General Practice, 2025, 28(17): 2070-2074.
|
[2] |
GU Jie, HUANG Yanyan.
Diagnosis and Comprehensive Management of Rare Diseases: the Indispensable Role of General Practitioners
[J]. Chinese General Practice, 2025, 28(16): 1955-1960.
|
[3] |
ZHAO Xiaoxiao, KE Lixin, XUN Yangqin, WANG Haibo, GAO Wulin, QIAO Tianci, LU Xiaohui, WU Jibiao, LU Cuncun.
Investigation and Future Trend Prediction of Disease Burden of Elderly Type 2 Diabetes Mellitus Globally and in China from 1990 to 2021
[J]. Chinese General Practice, 2025, 28(16): 2050-2058.
|
[4] |
SUI Hongping, LI Tingting, JIANG Tongtong, XIA Yunlong, SHI Tieying.
Research Progress on Blood Pressure Management of Vascular Endothelial Growth Factor Signaling Pathway Inhibitor-related Hypertension
[J]. Chinese General Practice, 2025, 28(15): 1932-1936.
|
[5] |
XIA Yuhan, ZHUO Xiao, CAO Qinhan, LIAO Xingyu, LUO Guoliang, TANG Taichun, CHEN Min.
Interpretation of the Updated NCCN Clinical Practice Guidelines for Colon Cancer (2024.V4)
[J]. Chinese General Practice, 2025, 28(14): 1689-1693.
|
[6] |
MA Guifen, ZHANG Qian, SUN Jing.
Interpretation of the Key Updates in the Latest Version of 2024 NCCN Clinical Practice Guidelines for Gastric Cancer
[J]. Chinese General Practice, 2025, 28(14): 1681-1688.
|
[7] |
WANG Jiangtao, DU Yu, ZHU Ling, ZHAO Fouxi, HU Yuandong, LIU Tao.
Correlation between Lipid Accumulation Product and the Incidence of Hypertension in Adults: a Prospective Cohort Study
[J]. Chinese General Practice, 2025, 28(12): 1433-1438.
|
[8] |
SHI Jian, WANG Yajing, HOU Ran, HUANG Yajie, DUAN Xiaoyang.
Efficacy and Safety of EGFR-TKI Combined with Chemotherapy for the First-line Treatment of EGFR-mutated Advanced Non-small Cell Lung Cancer: a Meta-analysis
[J]. Chinese General Practice, 2025, 28(11): 1383-1394.
|
[9] |
Chinese Academy Society of Sleep Medicine, Chinese Medical Doctor Association, Sleep Medicine Group, China Neurologist Association.
Chinese Guideline for Diagnosis and Treatment of Co-morbid Insomnia and Obstructive Sleep Apnea (2024)
[J]. Chinese General Practice, 2025, 28(11): 1289-1303.
|
[10] |
ZHOU Yiheng, LYU Yao, YANG Ziyu, YANG Rong, LIU Lidi, ZHANG Peng, DAI Hua, ZENG Rui, WAN Zhi, JIA Yu, LIU Changming, LEI Yi, LIAO Xiaoyang.
Interpretation of the Consensus Statement of the British and Irish Hypertension Societies on Adult Hypertension Referral Pathway and Therapeutic Management
[J]. Chinese General Practice, 2025, 28(10): 1173-1178.
|
[11] |
ZHANG Minrui, LI Dan, HE Meihui, GAO Ruixiang.
Do Higher Intellectuals Trust Traditional Chinese Medicine More?
[J]. Chinese General Practice, 2025, 28(09): 1044-1051.
|
[12] |
WANG Yiquan, CHEN Wanjia, LIU Wangyi, ZHANG Luyun, DENG Yueyi.
The Prognosis of Stage 4 Chronic Kidney Diseasetreated with Fermented Cordyceps Sinensis Powder: Based on a Retrospective Cohort Study
[J]. Chinese General Practice, 2025, 28(09): 1084-1091.
|
[13] |
Expert Group on the Consensus for Blood Purification Therapy Based on Pharmacokinetics in Acute Poisoning from Commonly Used Clinical Drugs.
Consensus for Blood Purification Therapy Based on Pharmacokinetics in Acute Poisoning from Commonly Used Clinical Drugs
[J]. Chinese General Practice, 2025, 28(09): 1033-1043.
|
[14] |
YANG Le, LI Zhenhao, YAO Dianrui, YANG Yang, SUN Yufang, HE Ying.
Cognitive Function of Older Adults Relocated for Poverty Alleviation and Its Influencing Factors
[J]. Chinese General Practice, 2025, 28(08): 939-947.
|
[15] |
GU Keyi, PAN Yaojia, HAN Zheng, FU Xiaoya, GU Handong, YANG Fei, WANG Weiqiang.
Correlation between Different Obesity Metabolic Phenotypes and Atherosclerosis in a Young Population: Uric Acid as Its Potential Factor
[J]. Chinese General Practice, 2025, 28(07): 831-837.
|